Maharah Human Resources Co. Announces an update on received the General Authority of Competition’s non-objection statement on completing the process of economic concentration between Growth Avenue Investment Company (“GAG") and Shifa Arabia Medical Company on03-06-1443H corresponding to 06-01-2022 G.

Element List	Explanation
Introduction	Reference to Maharah’s announcement on Tadawul website on 06-06-1443 H corresponding 09-01-2022 AD, regarding received the General Authority of Competition’s non-objection statement on completing the process of economic concentration between Growth Avenue Investment Company (“GAG") and Shifa Arabia Medical Company on 03-06-1443H corresponding to 06-01-2022 G.

Maharah would like to announce the completion of the transaction and the transfer of 85% of Shifa Arabia Medical Company shares to Growth Avenue Investment Company (“GAG") Previous Announcement received the General Authority of Competition’s non-objection statement on completing the process of economic concentration between Growth Avenue Investment Company (“GAG") and Shifa Arabia Medical Company on03-06-1443H corresponding to 06-01-2022 G. Date of Previous Announcement on Tadawul's Website 2022-01-09 Corresponding to 1443-06-06 Percentage of fulfilled achievement 100% Event's Expected Completion Date Not Applicable Reasons for Exceeding the Announced End Date Not Applicable The costs associated with the event, and if they have changed or not with indication of the reasons. None Impact of the Delay on the Company's Financial Results Not Applicable Additional Information Maharah would like to announce the completion of the transaction and the transfer of 85% of Shifa Arabia Medical Company shares to Growth Avenue Investment Company (“GAG")

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.